Metastatic Colorectal Cancers Completed Phase 4 Trials for Irinotecan (DB00762)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00138060Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic DeterminantsTreatment